These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29969030)

  • 1. Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile.
    Bautista-Aguilera ÓM; Budni J; Mina F; Medeiros EB; Deuther-Conrad W; Entrena JM; Moraleda I; Iriepa I; López-Muñoz F; Marco-Contelles J
    J Med Chem; 2018 Aug; 61(15):6937-6943. PubMed ID: 29969030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
    Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
    Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease.
    Knez D; Sova M; Košak U; Gobec S
    Future Med Chem; 2017 May; 9(8):811-832. PubMed ID: 28504893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease.
    Estrada Valencia M; Herrera-Arozamena C; de Andrés L; Pérez C; Morales-García JA; Pérez-Castillo A; Ramos E; Romero A; Viña D; Yáñez M; Laurini E; Pricl S; Rodríguez-Franco MI
    Eur J Med Chem; 2018 Aug; 156():534-553. PubMed ID: 30025348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
    J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties.
    Cai P; Fang SQ; Yang XL; Wu JJ; Liu QH; Hong H; Wang XB; Kong LY
    ACS Chem Neurosci; 2017 Nov; 8(11):2496-2511. PubMed ID: 28806057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases.
    Mathew B; Parambi DGT; Mathew GE; Uddin MS; Inasu ST; Kim H; Marathakam A; Unnikrishnan MK; Carradori S
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900177. PubMed ID: 31478569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids.
    Sun Y; Chen J; Chen X; Huang L; Li X
    Bioorg Med Chem; 2013 Dec; 21(23):7406-17. PubMed ID: 24128814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H
    Bautista-Aguilera ÓM; Hagenow S; Palomino-Antolin A; Farré-Alins V; Ismaili L; Joffrin PL; Jimeno ML; Soukup O; Janočková J; Kalinowsky L; Proschak E; Iriepa I; Moraleda I; Schwed JS; Romero Martínez A; López-Muñoz F; Chioua M; Egea J; Ramsay RR; Marco-Contelles J; Stark H
    Angew Chem Int Ed Engl; 2017 Oct; 56(41):12765-12769. PubMed ID: 28861918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
    Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
    Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
    Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
    J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciproxifan, a histamine H
    Hagenow S; Stasiak A; Ramsay RR; Stark H
    Sci Rep; 2017 Jan; 7():40541. PubMed ID: 28084411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual functional cholinesterase and MAO inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of homoisoflavonoid derivatives.
    Wang Y; Sun Y; Guo Y; Wang Z; Huang L; Li X
    J Enzyme Inhib Med Chem; 2016; 31(3):389-97. PubMed ID: 25798687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease.
    Joubert J; Foka GB; Repsold BP; Oliver DW; Kapp E; Malan SF
    Eur J Med Chem; 2017 Jan; 125():853-864. PubMed ID: 27744252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of novel monoamine oxidases and cholinesterases targeting compounds on brain neurotransmitters and behavior in rat model of vascular dementia.
    Stasiak A; Mussur M; Unzeta M; Samadi A; Marco-Contelles JL; Fogel WA
    Curr Pharm Des; 2014; 20(2):161-71. PubMed ID: 23701539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multitargeting Histamine H
    Łażewska D; Kaleta M; Zaręba P; Godyń J; Dubiel M; Honkisz-Orzechowska E; Doroz-Płonka A; Więckowska A; Stark H; Kieć-Kononowicz K
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid-β aggregation for the treatment of Alzheimer's disease.
    Yang HL; Cai P; Liu QH; Yang XL; Li F; Wang J; Wu JJ; Wang XB; Kong LY
    Eur J Med Chem; 2017 Sep; 138():715-728. PubMed ID: 28728104
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Bautista-Aguilera ÓM; Alonso JM; Catto M; Iriepa I; Knez D; Gobec S; Marco-Contelles J
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents.
    Košak U; Knez D; Coquelle N; Brus B; Pišlar A; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S
    Bioorg Med Chem; 2017 Jan; 25(2):633-645. PubMed ID: 27908752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.